Boots retail sales slump 18% due to lockdown


Boots stores continue to suffer as a result of lockdown restrictions with retail sales down 17.9 per cent on the previous year, parent company Walgreens Boots Alliance has said. 

Publishing the fiscal report for its second financial quarter in 2021, WBA said yesterday that reduced footfall was continuing to take its toll, particularly in major high streets, train stations and airports.

While the company has gained further market share in the beauty segment, all other retail segments have suffered.

However, the strong performance of Boots.com has held firm, with sales up 105 per cent compared to the same period in the previous fiscal year. 

Meanwhile, pharmacy sales at Boots rose by 3.2 per cent, with the company claiming that reduced script volume had been offset by “favourable timing of NHS reimbursement and stronger pharmacy services”.

Overall, gross profits for WBA’s international segment – which includes its UK operations such as Boots – were down 9.2 per cent compared to the previous year


This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to P3 Pharmacy's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.